ISNES, Belgium, July 26, 2022 (GLOBE NEWSWIRE) — ERC Belgium S.A. (ERC), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Sitoiganap (Gliovac or ERC1671) [...] Read more »